CMG Global Holdings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
CMG Global Holdings's ABBV Position: Q2 2026 in Review
CMG Global Holdings reduced its AbbVie (ABBV) stake by 0.53% in Q2 2026, selling an estimated $2.15K and leaving 1,869 shares worth $470K. The position accounts for 0.2% of the portfolio, ranked #63.
CMG Global Holdings first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. The position peaked at $757K in Q3 2024. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- CMG Global Holdings held 1,869 shares of AbbVie worth $470K as of Q2 2026.
- CMG Global Holdings sold 10 AbbVie shares in Q2 2026, an estimated $2.15K.
- AbbVie made up 0.2% of CMG Global Holdings's portfolio in Q2 2026, its #63 holding.
- CMG Global Holdings first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
- CMG Global Holdings's AbbVie position peaked at $757K in Q3 2024.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on CMG Global Holdings's 13F filing for Q2 2026, filed 28 Jul 2026.